LAC Med Bhd

LAC Med Bhd maintains a conservative capital structure with a debt-to-equity ratio of 0.23, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 2.11, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of MYR 13.75 million supports operational flexibility, though operating cash flow of MYR 376,350 is relatively low, indicating potential constraints in cash generation from operations. Profitability metrics show a return on equity (ROE) of 18.5% and a return on assets (ROA) of 10.22%, both exceeding the typical thresholds for the healthcare services and equipment industry. These figures suggest strong asset utilization and efficient capital deployment. Gross profit of MYR 58.57 million and operating income of MYR 31.76 million reflect a healthy margin structure, although the net income of MYR 21.99 million indicates some pressure from operating expenses. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segmental and geographic diversification may expose the company to higher operational and market-specific risks. LAC Med Bhd reported revenue of MYR 201.66 million in the latest period, with no specific growth trajectory provided in the input data. Analysts have assigned a mean price target of MYR 1.14, with a single "buy" recommendation and no "strong buy" or "hold" ratings, suggesting limited near-term upside potential. The risk assessment highlights a medium liquidity risk and a low dilution risk, with no significant dilution sources identified in the input data. However, the company's net cash position is negative after subtracting total debt, which could constrain its ability to fund operations or pursue growth opportunities without external financing. Recent events and filings do not include any material changes or disclosures in the input data, and no transcripts or earnings call summaries are provided to assess management commentary or strategic direction. The absence of recent events may limit visibility into the company's near-term performance drivers.